Epstein-Barr virus nuclear antigen-1 binds to nuclear transporter karyopherin α1/NPI-1 in addition to karyopherin α2/Rch1

Virology

Volumn 266, Issue 1, 2000, Pages 110-119

  Ito, Sayuri ^a   Ikeda, Masato ^a   Kato, Noriko ^a   Matsumoto, Akiko ^a   Ishikawa, Yuko ^a   Kumakubo, Satomi ^a   Yanagi, Kazuo ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CELL NUCLEUS ANTIGEN; COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; MONOCLONAL ANTIBODY; POLYPEPTIDE; VIRUS PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL LYSATE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING;

ANIMALIA; DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0034606695     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0054     Document Type: Article

References (61)

1. Aiyar A., Tyree C., Sugden B. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. EMBO J. 17:1998;6394-6403.
2. Ambinder R., Mullen M., Chang Y.-N., Hayward G. S., Hayward S. D. Functional domain of Epstein-Barr virus nuclear antigen EBNA-1. J. Virol. 65:1991;1466-1478.
3. Bruni R., Roizman B. Open reading frame P - A herpes simplex virus gene repressed during productive infection encodes a protein that binds a splicing factor and reduces synthesis of viral proteins made from spliced mRNA. Proc. Natl. Acad. Sci. USA. 93:1996;10423-10427.
4. Chen F., Zou J. Z., Renzo L., Winberg G., Hu L. F., Klein E., Klein G., Ernberg I. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69:1995;3752-3758.
5. Chen M.-R., Middeldorp J. M., Hayward S. D. Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J. Virol. 67:1993;4875-4885.
6. Chen M.-R., Yang J.-F., Middeldorp J. M., Chen J.-Y. Physical association between the EBV protein EBNA-1 and P32/TAP/hyaluronectin. J. Biomed. Sci. 5:1998;173-179.
7. Chien C.-T., Bartel P. L., Sternglanz R., Fields S. The two-hybrid system: A method to identify and clone genes for proteins that interact with a protein of interest. Proc. Natl. Acad. Sci. USA. 88:1991;9578-9582.
8. Conti E., Uy M., Leighton L., Blobel G., Kuriyan J. Crystallographic analysis of the recognition of a nuclear localization signal by the nuclear import factor karyopherin α Cell. 94:1998;193-204.
9. Cortes P., Ye Z., Baltimore D. RAG-1 interacts with the repeated amino acid motif of the human homologue of the yeast protein SRP1. Proc. Natl. Acad. Sci. USA. 91:1994;7633-7637.
10. Cuomo C. A., Kirch S. A., Gyuris J., Brent R. Rch1, a protein that specifically interacts with the RAG-1 recombination-activating protein. Proc. Natl. Acad. Sci. USA. 91:1994;6156-6160.
11. Davenport M. G., Pagano J. S. Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr Virus type 1 latency. J. Virol. 73:1999;3154-3161.
12. Fischer N., Kremmer E., Lautscham G., Mueller-Lantzsch N., Grasser F. A. EBNA-1 forms a complex with the nuclear transporter karyopherin α2. J. Biol. Chem. 272:1997;3999-4005.
13. Frappier L., O'Donnell M. Overproduction, purification, and characterization of EBNA-1, the origin binding protein of Epstein-Barr virus. J. Biol. Chem. 266:1991;7819-7826.
14. Fries K. L., Sculley T. B., Webster-Cyriaque J., Rajadurai P., Sadler R. H., Raab-Traub N. Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus. J. Virol. 71:1997;2765-2771.
15. Grasser F. A., Murray P. G., Kremmer E., Klein K., Remberger K., Feiden W., Reynolds G., Niedobitek G., Young L. S., Mueller-Lantzsch N. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): Immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood. 84:1994;3792-3798.
16. Haluska F. G., Finver S., Tsujimoto Y., Croce C. M. The t(8:14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining. Nature. 324:1986;158-161.
17. Hearing J. C., Levine A. J. The Epstein-Barr virus nuclear antigen (BamHI K antigen) is a single-stranded DNA binding phosphoprotein. Virology. 145:1985;105-116.
18. Honore B., Madsen P., Rasmussen H. H., Vandekerckhove J., Celis J. E., Leffers H. Cloning and expression of a cDNA covering the complete coding region of the P32 subunit of human pre-mRNA splicing factor SF2. Gene. 134:1993;283-287.
19. Inoue N., Harada S., Honma T., Kitamura T., Yanagi K. The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure. Virology. 182:1991;84-93.
20. Jans D. A. The regulation of protein transport to the nucleus by phosphorylation. Biochem. J. 311:1995;705-716.
21. Jiang J., Zhang Y., Krainer A. R., Xu R-M. Crystal structure of human p32, a doughnut-shaped acidic mitochondrial matrix protein. Proc. Natl. Acad. Sci. USA. 96:1999;3572-3577.
22. Kieff E. Epstein-Barr virus and its replication. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;2343-2396 Lippincott-Raven, Philadelphia.
23. Kim A. L., Maher M., Hayman J. B., Ozer J., Zerby D., Yates J. L., Lieberman P. M. An imperfect correlation between DNA replication activity of EBNA-1 and binding to the nuclear import receptor, Rch1/importin α Virology. 239:1997;340-351.
24. Kirchmaier A. L., Sugden B. Rep*: A viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus. J. Virol. 72:1998;4657-4666.
25. Kohler M., Ansieau S., Prehn S., Leutz A., Haller H., Hartmann E. Cloning of two novel human importin-α subunits and analysis of the expression pattern of the importin-α protein family. FEBS Lett. 417:1997;104-108.
26. Kube D., Vockerodt M., Weber O., Hell K., Wolf J., Haier B., Grasser F. A., Muller-Lantzsch N., Kieff E., Diehl V., Tesch H. Expression of Epstein-Barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428. J. Virol. 73:1999;1630-1636.
27. Lee M. A., Diamonod M. E., Yates J. L. Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus. J. Virol. 73:1999;2974-2982.
28. Levitskaya J., Coram M., Levitsky Victor, Imreh S., Steigerwald-Mullen P. M., Klein G., Kurilla M. G., Masucci M. G. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature. 375:1995;685-688.
29. Levitskaya J., Sharipo A., Leonchiks A., Ciechanover A., Masucci M. G. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl. Acad. Sci. USA. 94:1997;12616-12621.
30. Mackey D., Middleton T., Sugden B. Multiple regions within EBNA1 can link DNAs. J. Virol. 69:1995;6199-6208.
31. Malik H. S., Eickbush T. H., Goldfarb D. S. Evolutionary specialization of the nuclear targeting apparatus. Proc. Natl. Acad. Sci. USA. 94:1997;13738-13742.
32. Marechal V., Dehee A., Chikhi-Brachet R., Piolot T., Coppey-Moisan M., Nicolas J.-C. Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J. Virol. 73:1999;4385-4392.
33. Mattaj I. W., Englmeier L. Nucleocytoplasmic transport: The soluble phase. Annu. Rev. Biochem. 67:1998;265-306.
34. Matthews D. A., Russell W. C. Adenovirus core protein V interacts with p32-a protein which is associated with both the mitochondria and the nucleus. J. Gen. Virol. 79:1998;1677-1685.
35. Meissner J. D. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J. Gen. Virol. 80:1999;1725-1733.
36. Miyamoto Y., Imamoto N., Sekimoto T., Tachibana T., Seki T., Tada S., Enomoto T., Yoneda Y. Differential modes of nuclear localization signal (NLS) recognition by three distinct classes of NLS receptors. J. Biol. Chem. 272:1997;26375-26381.
37. Miyashita E. M., Yang B., Babcock G. J., Thorley-Lawson D. A. Identification of the site of EBV persistence in vivo as a resting B cell. J. Virol. 71:1997;4882-4891.
38. Nachury M. V., Ryder U. W., Lamond A. I., Weis K. Cloning and characterization of hSRP1γ, a tissue-specific nuclear transport factor. Proc. Natl. Acad. Sci. USA. 95:1998;582-587.
39. Nadler S. G., Tritschler D., Haffar O. K., Blake J., Bruce A. G., Cleaveland J. S. Differential expression and sequence-specific interaction of karyopherin α with nuclear localization sequences. J. Biol. Chem. 272:1997;4310-4315.
40. O'Neill R. E., Palese P. NPI-1, the human homolog of SRP-1, interacts with influenza virus nucleoprotein. Virology. 206:1995;116-125.
41. Petti L., Sample C., Kieff E. Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins. Virology. 176:1990;563-574.
42. Polvino-Bodnar M., Hiso J., Schaffer P. A. Mutational analysis of Epstein-Barr virus nuclear antigen 1 (EBNA 1). Nucleic Acids Res. 16:1988;3415-3435.
43. Polvino-Bodnar M., Schaffer P. A. DNA binding activity is required for EBNA1-dependent transcriptional activation and DNA replication. Virology. 187:1992;591-603.
44. Rickinson A. B., Kieff E. Epstein-Barr virus. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;2397-2446 Lippincott-Raven, Philadelphia.
45. Roth G., Tyler C., Lacy J. Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells. Blood. 84:1994;582-587.
46. Seki T., Tada S., Katada T., Enomoto T. Cloning of a cDNA encoding a novel importin-α homologue, Qip1: Discrimination of Qip1 and Rch1 from hSRP1 by their ability to interact with DNA helicase Q1/RecQL. Biochem. Biophys. Res. Commun. 234:1997;48-53.
47. Sekimoto T., Imamoto N., Nakajima K., Hirano T., Yoneda Y. Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rchl. EMBO J. 16:1997;7067-7077.
48. Sheu L.-F., Chen A., Meng C.-L., Ho K.-C., Lee W.-H., Leu F.-J., Chao C.-F. Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo. J. Pathol. 180:1996;243-248.
49. Shire K., Ceccarelli D. F. J., Avolio-Hunter T. M., Frappier L. EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. J. Virol. 73:1999;2587-2595.
50. Snudden D. K., Hearing J., Smith P. R., Grasser F. A., Griffin B. E. EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles "RGG" RNA binding proteins. EMBO J. 13:1994;4840-4847.
51. Srinivas S. K., Sixbey J. W. Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2. J. Virol. 69:1995;8155-8158.
52. Sung N. S., Wilson J., Davenport M., Sista N. D., Pagano J. S. Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor. Mol. Cell. Biol. 14:1994;7144-7152.
53. Takeda S., Fujiwara T., Shimizu F., Kawai A., Shinomiya K., Okuno S., Ozaki K., Katagiri T., Shimada Y., Magata M., Watanabe T., Takaichi A., Kuga Y., Suzuki M., Hishigaki H., Takahashi E., Shin S., Nakamura Y., Hirai Y. Isolation and mapping of karyopherin α3, a human gene that is highly homologous to genes encoding Xenopus importin, yeast SRP1 and human Rch1. Cytogenet. Cell Genet. 76:1997;87-93.
54. Wang P., Palese P., O'Neill R. E. The NPI-1/NPI-3 binding site on the influenza A virus nucleoprotein NP is a nonconventional nuclear localization signal. J. Virol. 71:1997;1850-1856.
55. Wang Y., Finan J. E., Middeldorp J. M., Hayward S. D. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus. Virology. 236:1997;18-29.
56. Weis K., Mattaj I. W., Lanmond A. I. Identification of hSRP1α as a functional receptor for nuclear localization sequences. Science. 268:1995;1049-1053.
57. Wilson J. B., Bell J. L., Levine A. J. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 15:1996;3117-3126.
58. Yates J. L., Camiolo S. M. Dissection of DNA replication and enhancer activation functions of Epstein-Barr virus nuclear antigen 1. Cancer Cells. 6:1988;197-205.
59. Yates J. L., Warren N., Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature. 313:1985;812-815.
60. Yu L., Loewenstein P. M., Zhang Z., Green M. In vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAP. J. Virol. 69:1995;3017-3023.
61. Zhang D., Frappier L., Gibbs E., Hurwitz J., O'Donnell M. Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein-Barr virus. Nucleic Acids Res. 26:1998;631-637.